Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1995
12/07/1995WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS
12/07/1995WO1995033048A2 P2x receptors (purinoceptor family)
12/07/1995WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c
12/07/1995WO1995032988A1 Novel parasite protease genes and proteins
12/07/1995WO1995032982A1 Dna encoding gls1
12/07/1995WO1995032724A1 Glial mitogenic factors, their preparation and use
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/07/1995DE4435919C1 DNA encoding zinc finger protein
12/07/1995CA2191306A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
12/07/1995CA2191085A1 Glial mitogenic factors, their preparation and use
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2191067A1 Dna encoding gls1
12/07/1995CA2190265A1 Hepatitis c virus asialoglycoproteins
12/07/1995CA2190254A1 Tumor necrosis factor receptor-associated factors
12/07/1995CA2189741A1 Novel parasite protease genes and proteins
12/07/1995CA2188449A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch
12/07/1995CA2167936A1 Tbp2 fragments of the transferrine receptor of neisseria meningitidis
12/07/1995CA2125240A1 Synthetic gene libraries
12/06/1995EP0685739A1 Method of detecting DAF molecules in feces
12/06/1995EP0685560A2 Method for controlling gene expression
12/06/1995EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate
12/06/1995EP0684994A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies
12/06/1995EP0684993A1 Human dna sequence encoding a kidney atp-dependent potassium channel
12/06/1995EP0684990A1 Novel receptor-type phosphotyrosine phosphatase-gamma
12/06/1995EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta
12/06/1995EP0684955A1 Nuclear matrix proteins
12/06/1995EP0684828A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
12/06/1995EP0466818B1 Monoclonal antibody recognizing a glycoprotein of human milk-fat globule membrane mucin antigen
12/06/1995EP0429542B1 Leukocyte adhesion inhibitor
12/06/1995CN1112932A Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and pral agentr their preparation
12/06/1995CN1030469C Heteropolysaccharide
12/05/1995US5473052 Antigen-binding fragments of an antibody to type-I collagen amino-terminal telopeptide
12/05/1995US5473051 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs
12/05/1995US5473049 Process for obtaining proinsulin possessing correctly linked cystine bridges
12/05/1995US5472939 Method of treating complement mediated disorders
12/05/1995US5472868 Stable rabbit-mouse fusion partner
12/05/1995US5472857 DNA encoding canine granulocyte colony stimulating factor (G-CSF)
12/05/1995US5472693 Monoclonal antibodies
11/1995
11/30/1995WO1995032310A1 Identification and use of antiviral compounds
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032292A2 Detection of viral antigens coded by reverse-reading frames
11/30/1995WO1995032291A2 Hepatitis g virus and molecular cloning thereof
11/30/1995WO1995032289A1 Transformant line of candida utilis yeast and expression of heterogene therewith
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032284A1 Factor interacting with nuclear proteins
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032224A1 Process for preparing antibody
11/30/1995WO1995032220A1 Cloned leptospira outer membrane protein
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995031901A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995CA2190999A1 Cloned leptospira outer membrane protein
11/30/1995CA2190860A1 Hepatitis g virus and molecular cloning thereof
11/30/1995CA2190613A1 Methods for the identification of compounds capable of abrogating hiv-1 vpr-rip-1 binding interactions
11/30/1995CA2190587A1 Identification and use of antiviral compounds
11/30/1995CA2188423A1 Factor interacting with nuclear proteins
11/29/1995EP0684313A2 Polypeptides with phytase activity
11/29/1995EP0684312A2 Preparation process of a natural protein sweetener
11/29/1995EP0684311A1 Vaccines against animal parasitic nematodes
11/29/1995EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/29/1995EP0683821A1 Rna packaging system
11/29/1995EP0683817A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof
11/29/1995EP0683675A1 Human monoclonal antibodies to cytomegalovirus
11/29/1995EP0460076B1 Genetically engineered immunoglobulins
11/29/1995EP0452314B1 Adhesion receptor for laminin and its use
11/29/1995EP0440689B1 Anti-idiotypic antibody induction of antitumor response
11/29/1995EP0412116B1 Detection of neu gene expression and products
11/29/1995EP0344320B1 Human monoclonal antibody against candida
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470956 Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470954 Antihemophelic factor separation by absorption
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470827 Method of producing iturin A and antifungal agent for profound mycosis
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470824 Method to treat Kaposi's sarcoma
11/28/1995US5470759 Anti-glycated hemoglobin monoclonal antibody and method for measuring glycated hemoglobin
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995US5470719 Nucleic acid code sequences
11/28/1995US5470573 Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174
11/28/1995US5470569 Genetic engineering
11/28/1995CA1337645C Teicoplanin-like derivatives
11/28/1995CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto
11/28/1995CA1337641C Recombinant dna product and method
11/28/1995CA1337640C Recombinant dna product and method
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031564A2 Method of introducing pathogen resistance in plants
11/23/1995WO1995031563A1 Complex inducible promoter system derivable from a phage of a lactic acid bacterium (lab), and its use in a lab for production of a desired protein
11/23/1995WO1995031561A1 Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031556A1 Glucan-binding proteins, and use thereof
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031549A1 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
11/23/1995WO1995031547A1 Brazzein sweetener
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein